The 21 CFR Part 11 Electronic Records Checklist Every QA Lead Should Run This Quarter

Twenty-something years after the FDA finalized 21 CFR Part 11, you would expect the regulation to be a solved problem. It is not. Warning letters and Form 483 observations citing Part 11 deficiencies have actually increased in the last five years, driven by two trends: regulated organizations are moving more of their quality records out of paper and into software, and the software they're moving them into was rarely designed with Part 11 in mind. The result is a quiet accumulation of risk inside spreadsheets, shared drives, and homegrown databases that look modern but cannot survive an inspection.

If you lead quality, regulatory, or IT validation at a biotech, pharma, medical device, CRO, or academic medical center, the most useful thing you can do this quarter is run a structured Part 11 self-assessment. Below is the checklist we use with our customers. It is not exhaustive — Part 11 has subparts and Subpart C is mostly about how you certify electronic signatures with the agency — but it covers the operational areas where teams lose points.

1. Validate that the system does what you say it does

Section 11.10(a) requires that closed systems used to create, modify, maintain, or transmit electronic records be validated to ensure accuracy, reliability, consistent intended performance, and the ability to discern invalid or altered records. In practice this means you need an Installation Qualification, an Operational Qualification, and ideally a Performance Qualification with traceable test scripts. The most common failure mode is treating the vendor's documentation as if it were your validation. It is not. The vendor's IQ/OQ proves the platform works in the abstract; your validation proves it works in your configuration, with your roles, with your data.

Action: confirm you have signed IQ/OQ documents on file for the current version of every Part 11 system you operate. If a system has been upgraded since the last validation, a change-control record and a regression validation summary should exist.

2. Make sure the audit trail is actually append-only

Section 11.10(e) requires secure, computer-generated, time-stamped audit trails that record the date and time of operator entries and actions that create, modify, or delete electronic records. The audit trail must be retained for at least as long as the underlying record and must be available for review and copying by the agency.

The audit-trail tests we run with customers are simple: can a system administrator delete or edit an audit-trail row? If yes, the system fails. Can a power user back-date an entry by changing their workstation clock or by passing a timestamp through an API? If yes, the system fails. Can an inspector export the trail in a human-readable format with before-and-after snapshots? If no, you will be writing a corrective action.

Action: have your IT team attempt — in a sandbox — to modify an audit-trail entry. Document the result. If the system permits modification, you either need a compensating control (like database-level immutability with cryptographic hashing) or you need a different system.

3. Tie every electronic signature to a meaning

Section 11.50 requires that signed electronic records contain the printed name of the signer, the date and time of the signature, and the meaning associated with the signature (such as review, approval, responsibility, or authorship). The meaning is the part teams forget. A signature that just says 'signed by Jane Doe at 14:32' is not Part 11 compliant. The record must show that Jane signed in her capacity as QA Manager for the purpose of approving Revision 3 of SOP-0042.

Action: pull a sample of ten recently signed records from your eQMS, eDMS, or eLN. For each one, confirm the printed name, the timestamp, and the explicit meaning are visible on the rendered record — not buried in a separate audit log that no one looks at.

4. Enforce real authentication, not shared logins

Sections 11.200 and 11.300 govern electronic signature components and controls. The two-component requirement (typically a unique user ID plus a password, but increasingly a passkey or SSO with MFA) must be enforced for every signature event, and the components must be unique to one individual. Shared logins, generic 'admin' accounts, and supervisor-overrides where one person enters their credentials on behalf of another are direct violations.

Action: run a query against your identity provider and your eQMS for any user account with more than one active session, any account whose password has not changed in 12+ months, and any account flagged 'service' or 'shared'. Those are your audit-trail risks.

5. Manage the lifecycle of every Part 11 user

Section 11.10(d) requires that access to the system be limited to authorized individuals. This is a joiner-mover-leaver problem. The most common observation we see is a former employee whose account is still active months after their last day, often because the IT team disabled the SSO account but never disabled the local account in the validated system. Every user-access review you complete should reconcile current employees against active accounts in every Part 11 system, not just your primary identity provider.

Action: compare your HR active-employee list against the user list in each Part 11 system. Disable any account that does not match, and document the reconciliation as part of your periodic access review.

How BioTrace handles this by default

BioTrace was built around these requirements rather than retrofitted into them. Every record is captured in a cryptographically chained, append-only ledger. Electronic signatures capture meaning, role, IP, and timestamp on the rendered record. Authentication is enforced through SSO with MFA, and the per-organization access review is a one-click export. None of this absolves you of running the checklist above — Part 11 is your responsibility, not your vendor's — but it dramatically shrinks the surface area of work you have to repeat manually each quarter.